RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
NCT04021368
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
112
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
High-risk Myelodysplastic Syndrome
Interventions
DRUG:
RVU120(SEL120)
Sponsor
Ryvu Therapeutics SA